| Particulars |
|
|
|
| Company Name
| Astrazeneca Pharma India Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
5.00 |
B.V. (₹) |
271.70 |
| Sales(₹ Cr.) |
1,295.53 |
NP (₹ Cr.) |
149.06 |
| NP Var% |
18.00 |
Div% |
1,200.00 |
| CPS(₹) |
65.60 |
EPS (₹) |
59.60 |
| Traded Value(₹ Lakhs) |
115.80 |
52 Week High |
9,199.00 |
| 52 Week Low |
5,181.00 |
Price BSE |
8,119.00 |
| Price NSE |
8,120.00 |
Market Capital (₹ Cr.) |
20,296.50 |
| P/C Ratio |
123.80 |
P/E Ratio |
136.20 |
| Price Vs.BV |
29.88 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
440.29 |
| NP(₹ Cr.) |
54.68 |
NP Var % |
246.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
1,484.51 |
| OPM |
12.70 |
NP |
128.73 |
| NP Var% |
5.10 |
EPS |
67.05 |
| PE |
121.08 |
|
|